Short CommunicationThe differential importance of mutations within AmpD in cephalosporin resistance of Enterobacter aerogenes and Enterobacter cloacae
Introduction
As a common hospital-associated pathogen, Enterobacter aerogenes can exhibit resistance to a variety of antimicrobials, including emerging resistance to carbapenems. Besides the acquisition of carbapenemases, changes in outer membrane permeability and overexpression of AmpC have been described as the main contributors to cephalosporin and carbapenem resistance [1], [2], [3], [4]. We recently reported highly carbapenem-resistant Enterobacter cloacae with no known carbapenemase, in which resistance was mediated by lesions in ampD and hyperproduction of AmpC [5]. In this study, we sought to define the contributions of these resistance mechanisms in a collection of carbapenem-resistant E. aerogenes isolates.
Section snippets
Clinical isolates and antimicrobial susceptibility testing
Twenty-three E. aerogenes isolates were tested. These included 18 ertapenem-resistant [minimum inhibitory concentrations (MICs) ≥ 2 mg/L] clinical isolates [15 submitted from different UK laboratories to Public Health England's Antimicrobial Resistance and Healthcare Associated Infections (AMRHAI) Reference Unit (London, UK) during 2012 and 2013 and 3 isolates from Basel, Switzerland (CH isolates)] and 5 isolates susceptible to carbapenems and third-generation cephalosporins that were included
Results
The basic characteristics of the 18 carbapenem-resistant E. aerogenes isolates were that they were genetically distinct by PFGE and were uniformly resistant to third-generation cephalosporins and ertapenem (median ertapenem MIC = 16 mg/L). Most were also non-susceptible, defined by clinical breakpoints, to meropenem and imipenem (15 and 17 isolates, respectively), with median MICs of 8 mg/L for both compounds. Six isolates were also resistant to cefepime (MICs > 4 mg/L) (Supplementary Fig. S1).
Discussion
In this diverse collection of ertapenem-resistant E. aerogenes isolates, we found that loss of Omp36, due to a combination of premature translation termination or reduced transcription, led to high-level meropenem resistance (MIC ≥ 16 mg/L), with disruption of the Omp36 coding sequence being observed in one-half of the carbapenem-resistant isolates.
All tested isolates lacked Omp35, suggesting that loss of Omp35 is primarily responsible for the ertapenem-resistant phenotype of E. aerogenes. With
Conclusion
Loss of Omp35 due to reduced transcription primarily led to an ertapenem-resistant phenotype in E. aerogenes, whereas loss of Omp36 led also to high-level meropenem resistance. Cephalosporin resistance was not dependent on mutations within AmpD, which contrasts with findings in E. cloacae.
Nucleotide sequence accession numbers
The accession numbers (for EMBL/GenBank/DDBJ) for the nucleotide sequence data in this study are as follows: KT894102 for ampC; KT894103 for ampR; KT894104 for ampD; KT894105 for omp35; and KT894106 for omp36 from NCTC 10336.
Acknowledgments
The authors would like to thank Dr Reno Frei and Dr Vladimira Hinic for providing the Swiss isolates. The authors would also like to thank Jayesh Shah, Claire Perry, Marina Warner, Ayisha Chaudry, Rachael Adkin, Jacqueline Findlay, Tabassum Noorie, Rachel Pike and Shazad Mushtaq for technical advice and assistance.
Funding: This study was supported by an award to BBF from Prof. Dr Max Cloëtta and Uniscienta Foundation and the Margarete and Walter Lichtenstein Foundation, University of Basel
References (20)
- et al.
In vivo selection of Enterobacter aerogenes with reduced susceptibility to cefepime and carbapenems associated with decreased expression of a 40 kDa outer membrane protein and hyperproduction of AmpC β-lactamase
Int J Antimicrob Agents
(2006) - et al.
A prevalent, multiresistant clone of Acinetobacter baumannii in Southeast England
J Hosp Infect
(2004) - et al.
Carbapenem resistance in a clinical isolate of Enterobacter aerogenes is associated with decreased expression of OmpF and OmpC porin analogs
Antimicrob Agents Chemother
(2002) - et al.
Successive emergence of Enterobacter aerogenes strains resistant to imipenem and colistin in a patient
Antimicrob Agents Chemother
(2005) - et al.
β-Lactamase expression and outer membrane protein changes in cefpirome-resistant and ceftazidime-resistant Gram-negative bacteria
J Antimicrob Chemother
(1991) - et al.
Association of novel nonsynonymous single nucleotide polymorphisms in ampD with cephalosporin resistance and phylogenetic variations in ampC, ampR, ompF and ompC in Enterobacter cloacae isolates that are highly resistant to carbapenems
Antimicrob Agents Chemother
(2016) Determination of minimum inhibitory concentrations
J Antimicrob Chemother
(2001)- et al.
Variation in clonality and antibiotic-resistance genes among multiresistant Salmonella enterica serotype Typhimurium phage-type U302 (MR U302) from humans, animals, and foods
Microb Drug Resist
(2001) - et al.
Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum β-lactamases
J Antimicrob Chemother
(2006) - et al.
Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR
J Clin Microbiol
(2002)
Cited by (16)
Molecular characterization of Enterobacter aerogenes isolated from urinary tract infections in Iran
2022, Acta TropicaCitation Excerpt :Of note, these bacteria can produce a low level of chromosomal β-lactamase cephalosporinase ampC that contributes to resistance to first-generation cephalosporins (Mallea et al., 1998; Naves et al., 2008; Qiu et al., 2013; Davin-Regli and Pagès, 2015). Chromosomally acquired resistance allows overproduction of this ampC cephalosporinase, as in the case of incubation with a subinhibitory amount of carbapenem (Babouee Flury et al., 2016; Shio-Shin et al., 2017; Zhou et al., 2018). The inactivation of ampR or acquisition of a plasmid ampC, overproduction of ampC β-lactamase contributes to resistance to third-generation cephalosporins (Tzelepi et al., 2000; Lee et al., 2002; Huang et al., 2012; Mezzatesta et al., 2012; Haidar et al., 2016).
Prevalence and mechanisms of extended-spectrum cephalosporin resistance in clinical and fecal Enterobacteriaceae isolates from dogs in Ontario, Canada
2018, Veterinary MicrobiologyCitation Excerpt :However, many of these were from species other than E. coli, in particular Enterobacter spp. (42/46) and Citrobacter spp. (4/4), which are known to be intrinsically resistant to ESCs and cefoxitin (http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Expert_Rules/Expert_rules_intrinsic_exceptional_V3.1.pdf). ESC resistance in these is usually caused by overexpression of chromosomal AmpC β-lactamases which is frequently seen in Enterobacter spp. (Livermore, 1995) or by other mechanisms such as porin modifications which were not investigated in this study (Babouee Flury et al., 2016). Despite this intrinsic resistance, four of the Enterobacter spp. isolates carried additional ESC resistance genes (Table 1).
Activity of ceftolozane-tazobactam and comparators against gram-negative bacilli: Results from the study for monitoring antimicrobial resistance trends (SMART – Brazil; 2016–2017)
2020, Brazilian Journal of Infectious DiseasesCitation Excerpt :This result was in concert with the observation of Robin et al.18 The hyperexpression of chromosomal AmpC could justify this result. In addition, association with other mechanisms of beta-lactam resistance could be present in these isolates, such as alteration in outer membrane protein(s), because the susceptibility rate to ertapenem was inferior to those observed for imipenem and meropenem.19 Previous studies have shown that AmpC hyperproducing E. cloacae isolates were usually resistant to ceftolozane-tazobactam.20
Filling knowledge gaps related to AmpC-dependent β-lactam resistance in Enterobacter cloacae
2024, Scientific ReportsEvaluation of in vitro antibacterial activity of carbapenems combined with colistin against drug-resistant Enterobacter cloacae complex
2020, Chinese Journal of Microbiology and Immunology (China)